HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Characterization of a new member of the human beta-adaptin gene family from chromosome 22q12, a candidate meningioma gene.

Abstract
A 140 kb homozygous deletion from 22q12 in one meningioma directed us towards the cloning and characterization of a new member of the human beta-adaptin gene family (named BAM22). Adaptins are essential for the formation of clathrin coated vesicles in the course of intracellular transport of receptor-ligand complexes. The BAM22 gene is totally inactivated in the tumor with homozygous deletion. Northern blot analysis of 70 sporadic meningiomas showed specific loss of expression in 8 tumors, suggesting inactivation of BAM22. Based on this, we propose BAM22 as a second chromosome 22 locus important in meningioma development, after the neurofibromatosis type 2 gene.
AuthorsM Peyrard, I Fransson, Y G Xie, F Y Han, M H Ruttledge, S Swahn, J E Collins, I Dunham, V P Collins, J P Dumanski
JournalHuman molecular genetics (Hum Mol Genet) Vol. 3 Issue 8 Pg. 1393-9 (Aug 1994) ISSN: 0964-6906 [Print] England
PMID7987321 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • AP1B1 protein, human
  • Adaptor Protein Complex 1
  • Adaptor Protein Complex beta Subunits
  • Membrane Proteins
Topics
  • Adaptor Protein Complex 1
  • Adaptor Protein Complex beta Subunits
  • Alternative Splicing
  • Base Sequence
  • Blotting, Northern
  • Chromosome Mapping
  • Chromosomes, Human, Pair 22
  • Cloning, Molecular
  • Gene Deletion
  • Humans
  • Membrane Proteins (genetics)
  • Meningeal Neoplasms (genetics)
  • Meningioma (genetics)
  • Molecular Sequence Data
  • Point Mutation (genetics)
  • Polymerase Chain Reaction
  • Polymorphism, Restriction Fragment Length

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: